Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25146295.
- Also identified by DOI 10.1126/science.1247391 and PMC identifier 4329726.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pluripotent stem cells (PSCs) directed to various cell fates holds promise as source material for treating numerous disorders. The availability of precisely differentiated PSC-derived cells will dramatically affect blood component and hematopoietic stem cell therapies and should facilitate treatment of diabetes, some forms of liver disease and neurologic disorders, retinal diseases, and possibly heart disease. Although an unlimited supply of specific cell types is needed, other barriers must be overcome. This review of the state of cell therapies highlights important challenges. Successful cell transplantation will require optimizing the best cell type and site for engraftment, overcoming limitations to cell migration and tissue integration, and occasionally needing to control immunologic reactivity, as well as a number of other challenges. Collaboration among scientists, clinicians, and industry is critical for generating new stem cell-based therapies.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Pluripotent Stem Cells
- Regeneration